Endo Pharmaceuticals Inc. - Citizen Petition

This Other document was issued by the Food and Drug Administration (FDA)

For related information, Open Docket Folder


Content

See attached file(s)

Attachments

 (10)

Endo Pharmaceuticals Inc Citizen Petition

View Attachment:
Authors: cder
 

Attachment 1 Butler et al Abuse Risks and Routes of Administration of Different Prescription Opioid Compounds and Formulations...

View Attachment:

Attachment 2 Confidential Information to be Submitted Under Separate Cover After Docket Number Assignment

View Attachment:

Attachment 3 Confidential Information to be Submitted Under Separate Cover After Docket Number Assignment

View Attachment:

Attachment 4 Confidential Information to be Submitted Under Separate Cover After Docket Number Assignment

View Attachment:

Attachment 5 Vosburg et al Experienced Opioid Abusers Attempt to Prepare a Crush Resistant Oxymorphone Extend Release Formulation...

Reason Restricted: This attachment is restricted to show metadata only. The reason is - study
 

Attachment 6 Confidential Information to be Submitted Under Separate Cover After Docket Number Assignment

View Attachment:

Attachment 7 Galia et al Oxymorphone ER Tablets With Improved Tamper Resistant Properties

Reason Restricted: This attachment is restricted to show metadata only. The reason is - study
 

Attachment 8 Proeschel et al Task Dependence of Activity Bite Force Relations and its Impact on Estimation of Chewing Force From...

Reason Restricted: This attachment is restricted to show metadata only because it contains copyrighted data.
 

see Attachment Order 2

Reason Restricted: This attachment is restricted to show metadata only. The reason is - see Attachment Order 2
 

 
 
Comment Period Closed
ID: FDA-2012-P-0951-0001

Document Information

Date Posted: Sep 26, 2012
Show More Details  

Submitter Information

Country: United States
State or Province: PA
Category: Private Industry - C0003

Comments

0
Comments Received*

Docket Information

This document is contained in

* This count refers to the total comment/submissions received on this document, as of 11:59 PM yesterday. Note: Agencies review all submissions, however some agencies may choose to redact, or withhold, certain submissions (or portions thereof) such as those containing private or proprietary information, inappropriate language, or duplicate/near duplicate examples of a mass-mail campaign. This can result in discrepancies between this count and those displayed when conducting searches on the Public Submission document type. For specific information about an agency’s public submission policy, refer to its website or the Federal Register document.